#161 – AMA #23: All Things Nicotine: deep dive into its cognitive and physical benefits, risks, and mechanisms of action
“It’s so fascinating to me frankly that one molecule found in nature can be so potent. It’s hard to imagine you could engineer a drug to do this.” —Peter Attia
#160 – Paul Offit, M.D.: The latest on COVID-19 vaccines and their safety, herd immunity, and viral variants
“If you ask me the question, ‘What do I fear most about this whole pandemic?’ it’s actually not the variants. … It’s that there would be a significant percentage of the population that is going to choose not to vaccinate so much so that we can’t get to that 80+% of population immunity we need to slow this virus.” —Paul Offit
#159 – Peter Hotez, M.D., Ph.D.: Evolution of the anti-vaccine movement, the causes of autism, and COVID-19 vaccine state of affairs
“What started out as an anti-vaccine movement is now a movement against any kind of public health intervention and demonizing scientists and basically calling us the boogeyman.” —Peter Hotez
mRNA vaccine technology
Science builds on science
Metformin and COVID-19 mortality risk; a timeline of Kobe’s last day
A few things worth checking out: 03-28-2021
#150 – Senator Bill Frist, M.D.: A modern Renaissance man’s journey through science, politics, and business
“Public health has been the stepchild of health and welfare and healing. That is inverted now, and people appreciate it, but are we going to actually deliver on it? Not just next year, and not just put more funding in it, but really do it over a period of time?” —Bill Frist
A win for Topo Chico; COVID-19 vaccine second dose
A few things worth checking out: 02-21-2021
Should you get the COVID-19 vaccine?
Thoughts from a friend
Does vitamin D deficiency raise COVID-19 risk?
Expectations for vitamin D and COVID-19
#143 – John Ioannidis, M.D., D.Sc.: Why most biomedical research is flawed, and how to improve it
“We need to defend our method. We need to defend our principles. We need to defend the honesty of science in trying to communicate it rather than building exaggerated promises or narratives that are not realistic.” —John Ioannidis